These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 19156669)
1. Pharmacodynamics of glucose regulation by methylprednisolone. II. normal rats. Jin JY; Jusko WJ Biopharm Drug Dispos; 2009 Jan; 30(1):35-48. PubMed ID: 19156669 [TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats. Jin JY; Jusko WJ Biopharm Drug Dispos; 2009 Jan; 30(1):21-34. PubMed ID: 19156931 [TBL] [Abstract][Full Text] [Related]
3. Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats. Fang J; DuBois DC; He Y; Almon RR; Jusko WJ J Pharmacokinet Pharmacodyn; 2011 Jun; 38(3):293-316. PubMed ID: 21394487 [TBL] [Abstract][Full Text] [Related]
4. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression. Ayyar VS; DuBois DC; Nakamura T; Almon RR; Jusko WJ J Pharmacol Exp Ther; 2019 Aug; 370(2):327-336. PubMed ID: 31197019 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression. Sukumaran S; Jusko WJ; DuBois DC; Almon RR J Pharmacol Exp Ther; 2011 Jun; 337(3):734-46. PubMed ID: 21398515 [TBL] [Abstract][Full Text] [Related]
6. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids. Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):643-67. PubMed ID: 17593325 [TBL] [Abstract][Full Text] [Related]
16. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat. Ayyar VS; Song D; DuBois DC; Almon RR; Jusko WJ J Pharmacol Exp Ther; 2019 Aug; 370(2):318-326. PubMed ID: 31197020 [TBL] [Abstract][Full Text] [Related]
17. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor-Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids. Ayyar VS; DuBois DC; Almon RR; Jusko WJ J Pharmacol Exp Ther; 2019 Aug; 370(2):337-349. PubMed ID: 31197018 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation. Mishina EV; Jusko WJ Pharm Res; 1994 Jun; 11(6):848-54. PubMed ID: 7937524 [TBL] [Abstract][Full Text] [Related]
20. Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing. Yao Z; Hoffman EP; Ghimbovschi S; Dubois DC; Almon RR; Jusko WJ Mol Pharm; 2008; 5(2):328-39. PubMed ID: 18271548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]